Encouraging First-Half Results for Lek
Ljubljana, 13 July - Slovene pharmaceutical company Lek reported that its half-yearly sales for 2001 amounted to 34.5 billion tolars (158 million euros), a jump of 26 percent over the same period last year. Sales in the first half of 2000 thus amounted to 55 percent of the yearly sales forecasts, added the company.
The rest of this news item is available to subscribers.
The news item consists of 331 characters (without spaces) or 67 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.